In 2018, DSM made a series of bets in personalized nutrition, engaging with Mixfit, Tespo, and DeNA Life Science. In 2019, it has reinforced those moves by forming partnerships with Panaceutics and WellMetrix in April and October, respectively, as well as acquiring AVA in November. DSM formed a commercial partnership with Panaceutics, exclusively selling the company's fruit puree pouches in the Americas, Europe, and Asia. Meanwhile, its partnership with WellMetrix is research-focused, looking into the efficacy of the organization's urine-based biomarker analysis versus established urine and blood tests. With the purchase of AVA, DSM is gaining access to an online platform that provides nutrition recommendations and coaching.